Logo image of GBIO

GENERATION BIO CO (GBIO) Stock Analyst Earnings Estimates

NASDAQ:GBIO - Nasdaq - US37148K1007 - Common Stock - Currency: USD

0.6102  0 (-0.78%)

After market: 0.6096 0 (-0.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
GBIO revenue by date.GBIO revenue by date.
5.904M18.464M
212.74%
7.239M
-60.79%
7.964M
10.02%
10.921M
37.13%
11.487M
5.18%
23.658M
105.95%
99.193M
319.28%
175.32M
76.75%
443.2M
152.79%
EBITDA
YoY % growth
GBIO ebitda by date.GBIO ebitda by date.
-114.57M
-47.49%
-130.25M
-13.69%
-133.3M
-2.34%
-136.68M
-2.54%
-85.68M
37.31%
-87.72M
-2.38%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
GBIO ebit by date.GBIO ebit by date.
-119.1M
-46.84%
-135.38M
-13.67%
-138.563M
-2.35%
-135.628M
2.12%
-90.753M
33.09%
-95.043M
-4.73%
-93.987M
1.11%
-62.681M
33.31%
-48.507M
22.61%
-53.011M
-9.29%
13.117M
124.74%
116.59M
788.85%
Operating Margin
GBIO operating margin by date.GBIO operating margin by date.
N/AN/A-2,346.93%-734.55%-1,253.66%-1,193.41%-860.61%-545.67%-205.03%-53.44%7.48%26.31%
EPS
YoY % growth
GBIO eps by date.GBIO eps by date.
-2.11
26.90%
-2.35
-11.37%
-1.96
16.60%
-1.87
4.39%
-1.10
41.43%
-0.98
10.94%
-0.68
30.09%
-0.77
-11.94%
-0.70
8.00%
0.39
155.07%
0.21
-44.74%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.31
41.99%
-0.30
73.10%
-0.30
3.40%
-0.27
-16.01%
-0.27
12.48%
-0.28
6.23%
-0.28
5.65%
-0.24
11.51%
-0.23
13.95%
Revenue
Q2Q % growth
2.55M
-11.40%
1.428M
-64.82%
1.428M
-65.09%
1.403M
-81.43%
1.403M
-44.98%
56.61K
-96.04%
56.61K
-96.04%
56.61K
-95.97%
56.61K
-95.97%
EBITDA
Q2Q % growth
-15.3M
53.86%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-22.583M
41.22%
-22.44M
-8.38%
-21.42M
1.80%
-22.44M
-34.25%
-22.44M
0.63%
-22.95M
-2.27%
-22.95M
-7.14%
-23.46M
-4.55%
-23.46M
-4.55%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.23
46.51%
-0.290.0620.20%
Q2 2024
Q2Q % growth
-0.31
34.04%
-0.28-0.03-9.16%
Q1 2024
Q2Q % growth
-1.12
-111.32%
-0.42-0.70-169.03%
Q4 2023
Q2Q % growth
-0.53
3.64%
-0.46-0.07-15.84%
Q3 2023
Q2Q % growth
-0.43
18.87%
-0.520.0916.52%
Q2 2023
Q2Q % growth
-0.47
28.79%
-0.510.047.26%
Q1 2023
Q2Q % growth
-0.53
13.11%
-0.47-0.06-11.91%
Q4 2022
Q2Q % growth
-0.55
-1.85%
-0.590.046.83%
Q3 2022
Q2Q % growth
-0.53
5.36%
-0.680.1522.61%
Q2 2022
Q2Q % growth
-0.66
-20.00%
-0.64-0.02-3.89%
Q1 2022
Q2Q % growth
-0.61
-32.61%
-0.54-0.07-13.91%
Q4 2021
Q2Q % growth
-0.54
-100.00%
-0.580.047.12%
Q3 2021
Q2Q % growth
-0.56
-21.74%
-0.570.011.37%
Q2 2021
Q2Q % growth
-0.55
63.33%
-0.48-0.07-15.43%
Q1 2021
Q2Q % growth
-0.46 -0.460.00-0.22%
Q4 2020
Q2Q % growth
-0.27 -0.510.2447.41%
Q3 2020
Q2Q % growth
-0.46 -0.460.000.34%
Q2 2020
Q2Q % growth
-1.50 -0.61-0.89-144.08%
GBIO Yearly EPS VS EstimatesGBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
7.554M
252.00%
1.92M5.634M293.44%
Q2 2024
Q2Q % growth
4.091M
364.89%
1.999M2.092M104.65%
Q1 2024
Q2Q % growth
4.059M 1.958M2.101M107.30%
Q4 2023
Q2Q % growth
2.878M 877.2K2.001M228.09%
Q3 2023
Q2Q % growth
2.146M 1.115M1.031M92.47%
Q2 2023
Q2Q % growth
880K 3.622M-2.742M-75.70%
Q1 2023
Q2Q % growth
8.075M-8.075M-100.00%
Q2 2022
Q2Q % growth
1.53M-1.53M-100.00%
Q1 2022
Q2Q % growth
1.53M-1.53M-100.00%
GBIO Yearly Revenue VS EstimatesGBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.94% 4.09% 0.16% 1%
Revenue31.58% 31.58% 0% 8.57%